Get the Stockscreener App
52.47
2.09%
-1.12
After Hours:
52.50
0.03
+0.06%
Tempus Ai Inc stock is traded at $52.47, with a volume of 3.89M.
It is down -2.09% in the last 24 hours and up +7.54% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$53.59
Open:
$52.01
24h Volume:
3.89M
Relative Volume:
0.61
Market Cap:
$9.42B
Revenue:
$1.36B
Net Income/Loss:
$-302.91M
P/E Ratio:
-30.54
EPS:
-1.7182
Net Cash Flow:
$-219.93M
1W Performance:
-9.89%
1M Performance:
+7.54%
6M Performance:
-25.39%
1Y Performance:
-13.49%
1-Day Range:
$51.23
$53.50
1-Week Range:
$51.23
$59.94
52-Week Range:
$41.73
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
52.47 | 9.62B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
195.38 | 32.06B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
70.69 | 13.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
97.67 | 8.25B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
87.09 | 6.65B | 646.34M | -512.40M | 202.76M | -6.6871 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Jefferies | Underperform |
| Apr-13-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-19-26 | Initiated | Mizuho | Outperform |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
Artificial Intelligence Stocks To Follow NowJuly 18th - MarketBeat
Tempus AI Expands Cancer Platform With Launch of ArteraAI Prostate Test For Metastatic Patients - Stocktwits
Guggenheim raises Tempus AI stock price target to $65 on estimates By Investing.com - Investing.com Australia
TEM Maintains Buy Rating by Guggenheim -- Price Target Raised to $65 - GuruFocus
Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service - Business Wire
Guggenheim raises Tempus AI stock price target to $65 on estimates - Investing.com
Best Artificial Intelligence Stocks To ConsiderJuly 15th - MarketBeat
Canal Insurance CO Acquires 20,000 Shares of Tempus AI, Inc. $TEM - MarketBeat
Tempus AI plans $350M convertible notes offering - MSN
Tempus AI's healthcare data segment revenue jum... - Pluang
Tempus AI: Building Ultimate Healthcare Data Dominance (NASDAQ:TEM) - Seeking Alpha
Tempus AI Stock (TEM) Opinions on Analyst Price Targets and Valuation Breakdowns - Quiver Quantitative
Tempus AI: The Market Is Betting On An Inflection I Can't Yet See (NASDAQ:TEM) - Seeking Alpha
BofA Securities Maintains Tempus AI(TEM.US) With Hold Rating, Maintains Target Price $64 - Moomoo
Tempus AI, Inc. (TEM) Stock Report: Navigating Growth Amid A 13.45% Potential Upside - DirectorsTalk Interviews
Diversify Wealth Management LLC Raises Stock Position in Tempus AI, Inc. $TEM - MarketBeat
Artificial Intelligence Stocks To ConsiderJuly 12th - MarketBeat
Morgan Stanley Remains a Buy on Tempus AI, Inc. Class A (TEM) - The Globe and Mail
Tempus AI’s Ryan Fukushima, CEO, data, sells $1.91m in stock By Investing.com - Investing.com Australia
Form 4 Tempus AI Inc For: 10 July By Investing.com - Investing.com Nigeria
Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells $1,910,168.76 in Stock - MarketBeat
Tempus AI’s Ryan Fukushima, CEO, data, sells $1.91m in stock - Investing.com Nigeria
Tempus AI (TEM) officer logs 33,284-share spouse sale under Rule 10b5-1 plan - Stock Titan
Sumitomo Mitsui Trust Group Inc. Raises Position in Tempus AI, Inc. $TEM - MarketBeat
TEM Stock Price Prediction 2025-2026 | Tempus AI, Inc. Class A Common Stock Forecast - 24/7 Wall St.
Artificial Intelligence Stocks To Keep An Eye OnJuly 9th - MarketBeat
Tempus to Report Second Quarter 2026 Financial Results on July 30 - Business Wire
Press Release: Tempus to Report Second Quarter 2026 Financial Results on July 30 - Moomoo
Tempus AI (TEM) Q3 2025 earnings summary - Quartr
Form 144 TEMPUS AI INC For: 8 July By Investing.com - Investing.com UK
Form 4 Tempus AI Inc For: 8 July By Investing.com - Investing.com Canada
Morgan Stanley Smith Barney (TEM) files resale notice for 33,284 shares - Stock Titan
Tempus AI CEO, data Fukushima sells $600,000 in stock By Investing.com - Investing.com Nigeria
Tempus AI CEO, data Fukushima sells $600,000 in stock - Investing.com
Rule 10b5-1 sale by Tempus AI (TEM) officer’s spouse trims holdings - Stock Titan
Tempus AI stock initiated at Hold by Freedom Capital with $59 target By Investing.com - Investing.com South Africa
Tempus AI stock initiated at Hold by Freedom Capital with $59 target - Investing.com South Africa
Freedom Capital Initiates Coverage of Tempus AI, Inc. (TEM) - Yahoo Finance
Tempus, USC Partner to Accelerate AI-Driven Precision Medicine - Medical Product Outsourcing
Tempus AI, Inc. $TEM Shares Bought by Janney Montgomery Scott LLC - MarketBeat
Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH - AOL.com
Tempus AI(TEM) Stock Options Chain | Quotes & News - Moomoo
Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - AOL.com
Form 144 Tempus AI For: 6 July By Investing.com - Investing.com Nigeria
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.03%
1.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):